---
figid: PMC11652361__fimmu-15-1490505-g002
figtitle: Illustration of osteoclasts differentiation
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11652361
filename: fimmu-15-1490505-g002.jpg
figlink: /pmc/articles/PMC11652361/figure/F2/
number: F2
caption: Illustration of osteoclasts differentiation. Siglec-15 can bind CD44 on osteoclast
  precursors via the DAP 12-SYK signaling pathway, which interacts with the RANKL-RANK-TRAF
  6 pathway, thereby amplifying the expression of downstream signaling molecules like
  ERK and PI3K-AKT
papertitle: 'Siglec15 in blood system diseases: from bench to bedside'
reftext: Yujia Fan, et al. Front Immunol. 2024;15(NA).
year: '2024'
doi: 10.3389/fimmu.2024.1490505
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media SA
keywords: Siglec-15 | immune checkpoint | osteoclasts | microbial infection | immunotherapy
  | hematological diseases
automl_pathway: 0.9668153
figid_alias: PMC11652361__F2
figtype: Figure
redirect_from: /figures/PMC11652361__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11652361__fimmu-15-1490505-g002.html
  '@type': Dataset
  description: Illustration of osteoclasts differentiation. Siglec-15 can bind CD44
    on osteoclast precursors via the DAP 12-SYK signaling pathway, which interacts
    with the RANKL-RANK-TRAF 6 pathway, thereby amplifying the expression of downstream
    signaling molecules like ERK and PI3K-AKT
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD44
  - TNFSF11
  - SIGLEC15
  - SYK
  - TRAF6
  - TYROBP
  - TNFRSF11A
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
---
